BAILARD, INC. Q4 2021 Filing
Filed February 10, 2022
Portfolio Value
$3.1T
Holdings
712
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (712 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 701 | LCTXLINEAGE CELL THERAPEUTICS IN | 63,400 | $155.0M | 0.00% | |
| 702 | OVIDOVID THERAPEUTICS INC | 47,948 | $154.0M | 0.00% | |
| 703 | —BIOCEPT INC | 42,100 | $152.0M | 0.00% | |
| 704 | NHSNEUBERGER BERMAN HIGH YIELD | 10,839 | $135.0M | 0.00% | |
| 705 | ERICERICSSON | 11,623 | $126.0M | 0.00% | |
| 706 | —BIO-PATH HLDGS INC | 33,521 | $126.0M | 0.00% | |
| 707 | DNOWNOW INC | 13,391 | $114.0M | 0.00% | |
| 708 | HBIOHARVARD BIOSCIENCE INC | 14,700 | $104.0M | 0.00% | |
| 709 | SLDBSOLID BIOSCIENCES INC | 53,400 | $93.0M | 0.00% | |
| 710 | CTVHELIX ENERGY SOLUTIONS GRP I | 28,600 | $89.0M | 0.00% | |
| 711 | SANBANCO SANTANDER S.A. | 19,396 | $64.0M | 0.00% | |
| 712 | CBAYUSDCYMABAY THERAPEUTICS INC | 13,700 | $46.0M | 0.00% |
PreviousPage 8 of 8